Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 19 May 2023
USA: Compared to a placebo, cemiplimab plus chemotherapy can increase survival and improve quality of life in patients with advanced lung cancer.
Read Full NewsForget salary. The cities winning the physician satisfaction race are playing a completely different game.
The prevalence of type 2 diabetes is rising among US youth, and if we don’t address the real causes, we really will see a potentially unstoppable surge.
Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.
Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.
The Red Cross on Saturday paid tribute to three volunteers who are believed to have died after contracting Ebola while handling bodies.
Americans coming back from the Democratic Republic of the Congo, Uganda or South Sudan now have a second entry point for returning to the United States, with the CDC on...
1.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
2.
Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
A new device enhances liquid biopsy.
5.
Waiting for a Sharp Increase in Prostate Cancer Cases.
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Exploring Dyscrasias: Uncovering the Causes and Treatments of Unusual Blood Disorders
3.
Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration
4.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
5.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
2.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge